Author: Matsuo, Keisuke; Ishiguro, Takashi; Najama, Takatomo; Shimizu, Yoshihiko; Kobayashi, Yasuhito; Mutou, Makoto
Title: Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature Document date: 2019_5_22
ID: y2n9z5sd_1
Snippet: Nivolumab is an immune checkpoint inhibitor (ICI) that has become a new treatment option for malignant tumors. While initially proven effective for melanoma, the diseases for which this agent is administered have been expanding. However, a number of immune-related adverse events (ir-AEs), which are rarely seen in conventional chemotherapy, have been reported with this drug, and as the frequency of its use increases, there are concerns that the nu.....
Document: Nivolumab is an immune checkpoint inhibitor (ICI) that has become a new treatment option for malignant tumors. While initially proven effective for melanoma, the diseases for which this agent is administered have been expanding. However, a number of immune-related adverse events (ir-AEs), which are rarely seen in conventional chemotherapy, have been reported with this drug, and as the frequency of its use increases, there are concerns that the number of side effects will also increase.
Search related documents:
Co phrase search for related documents- adverse event and conventional chemotherapy: 1
- adverse event and drug report: 1, 2, 3, 4
- adverse event and effect number: 1
- adverse event and ICI immune checkpoint inhibitor: 1, 2
- adverse event and immune checkpoint inhibitor: 1, 2, 3, 4, 5
- adverse event and treatment option: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- checkpoint inhibitor and conventional chemotherapy: 1
- checkpoint inhibitor and ICI immune checkpoint inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- checkpoint inhibitor and immune checkpoint inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68
- checkpoint inhibitor and malignant tumor: 1
- checkpoint inhibitor and treatment option: 1, 2
- conventional chemotherapy and malignant tumor: 1
- conventional chemotherapy and treatment option: 1, 2
- drug report and treatment option: 1
Co phrase search for related documents, hyperlinks ordered by date